The on-going JANUS project was initiated by the Norwegian Cancer Socie
ty in 1973. The serum bank comprises close to 0.5 million serum sample
s collected from 170 000 donors. From 2-16 consecutive samples are ava
ilable from each donor. The sera are stored at -25-degrees-C. At regul
ar intervals the JANUS-collection is matched against the files of the
Norwegian Cancer Registry. From 1973 to 1991 almost 5000 of the donors
have developed some form of cancer. Frozen serum samples collected fr
om a few months to 18 years prior to clinical recognition of their dis
ease are consequently available for research purposes. The aim of the
JANUS-project is to search in these premorbid sera for chemical, bioch
emical, immunological or other changes that might be indicative of can
cer development at early stages. Gas chromatography-mass spectrometry
and two-dimensional protein electrophoresis have been used to evaluate
the stability of the frozen sera. Some recent findings are: CA125 is
elevated several months prior to diagnosis of ovarian cancer; serum th
yroglobulin may be a preclinical tumour marker in subgroups of thyroid
cancer; low level of selenium in serum reflects increased risk of thy
roid cancer; and raised antibodies in serum against Epstein-Barr virus
is a risk factor for development of Hodgkin's disease. On-going resea
rch includes trace elements and cancer, and studies on lipid-profiles,
diet and cancer. The serum bank may in principle be used for other pu
rposes, e.g. in environmental studies. Analysis of sequential sera may
determine chemical substances in the sera that might reflect differen
ces in exposure to environmental pollutants in the period 1973-1991.